AR and metastatic neoplasm: This is based on the result of studies showing that, while uncommon in hormonally naïve patients, AR gene mutation and amplification, resulting in elevated AR protein expression, are detected in the majority of metastatic prostate cancer tissues obtained from patients with castrate-resistant metastatic disease [12], [13].